Delivery Order SPE2DR25D2104-SPE2DR26F3QMB
Award Date 12/4/25
Potential Completion Date 12/5/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,171.24 to AmerisourceBergen Drug Corp for Exforge HCT 10-160-12.5 mg tablets (30-count supply) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Exforge HCT 10-320-25 mg tablets in a 30-count package. This competitively awarded, non-set-aside contract carries a ceiling value of $1,617.29 under a firm fixed price arrangement, with an ultimate completion date of December 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters...
- The Defense Logistics Agency awarded a $22,617.45 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Exforge 10-320 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with a completion date of December 11, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count) under a firm fixed price contract valued at $1,388.87. This is a non-set-aside delivery order with an ultimate completion date of November 5, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.54 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count bottles) on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and represents a single pharmaceutical supply transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $15,095.94 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Exforge 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,701.12 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 5-160-12.5 mg tablets (30-count package), a combination antihypertensive medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on September 22, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $3,788.86 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Exforge 10-160 mg tablets (30-count packaging). This is a firm fixed-price delivery order with a completion date of May 13, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count) with a ceiling value of $11,442.50. This firm fixed-price delivery order, without a set-aside designation, represents a competitively awarded contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...